Arcutis Biotherapeutics Inc. logo

Arcutis Biotherapeutics Inc. (ARQT)

Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
23. 75
-0.22
-0.9178%
$
3B Market Cap
- P/E Ratio
- Div Yield
1.06M Volume
-3.88 Eps
$ 23.97
Previous Close
Add Transaction
Day Range
23.54 24.11
Year Range
15.13 31.77
Want to track ARQT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Arcutis Biotherapeutics Inc. logo
ARQT Arcutis Biotherapeutics Inc.
5 May 2026
-
-
Arcutis Biotherapeutics Inc. logo
ARQT Arcutis Biotherapeutics Inc.
24 Feb 2026
0.02
-
Arcutis Biotherapeutics Inc. logo
ARQT Arcutis Biotherapeutics Inc.
4 Nov 2025
-
-
Arcutis Biotherapeutics Inc. logo
ARQT Arcutis Biotherapeutics Inc.
13 Aug 2025
-
-
Arcutis Biotherapeutics Inc. logo
ARQT Arcutis Biotherapeutics Inc.
12 May 2025
-
-
Arcutis Biotherapeutics Inc. logo
ARQT Arcutis Biotherapeutics Inc.
25 Feb 2025
-
-
Arcutis Biotherapeutics Inc. logo
ARQT Arcutis Biotherapeutics Inc.
1 Nov 2024
-
-
Arcutis Biotherapeutics Inc. logo
ARQT Arcutis Biotherapeutics Inc.
6 Aug 2024
-
-
Arcutis Biotherapeutics Inc. logo
ARQT Arcutis Biotherapeutics Inc.
14 Jun 2024
-
-
Arcutis Biotherapeutics Inc. logo
ARQT Arcutis Biotherapeutics Inc.
27 Feb 2024
-
-
Arcutis Biotherapeutics Inc. logo
ARQT Arcutis Biotherapeutics Inc.
3 Nov 2023
-
-

ARQT Earnings Reports FAQ

What is the earnings per share (EPS) for ARQT?

The current EPS is -3.88.

What is the company's earnings growth rate?

Arcutis Biotherapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Arcutis Biotherapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Arcutis Biotherapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for ARQT at this time, as Arcutis Biotherapeutics Inc has no recent EPS data to calculate it.